| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0002A |
|
491 |
485 |
$23K |
| 0001A |
|
510 |
497 |
$19K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
74 |
66 |
$15K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
142 |
129 |
$4K |
| 0071A |
|
36 |
33 |
$3K |
| 0072A |
|
32 |
32 |
$3K |
| 0003A |
|
47 |
47 |
$1K |
| 0012A |
|
129 |
126 |
$661.95 |
| 0011A |
|
117 |
114 |
$557.16 |
| 90686 |
|
14 |
14 |
$145.26 |
| G0008 |
Administration of influenza virus vaccine |
131 |
128 |
$123.60 |
| 0013A |
|
42 |
42 |
$120.00 |
| 91300 |
|
873 |
790 |
$7.87 |
| 91307 |
|
85 |
69 |
$0.80 |
| 91301 |
|
25 |
25 |
$0.18 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
29 |
29 |
$0.15 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
20 |
16 |
$0.09 |
| 90480 |
|
130 |
125 |
$0.00 |
| 90656 |
|
17 |
16 |
$0.00 |
| M0201 |
Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patient's home; reported only once per individual home per date of service when such vaccine administration(s) are performed at the patient's home |
31 |
30 |
$0.00 |
| 90694 |
|
49 |
49 |
$0.00 |
| 91322 |
|
130 |
125 |
$0.00 |
| 90653 |
|
38 |
37 |
$0.00 |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
12 |
12 |
$0.00 |